Iduronate-2-sulfatase (3.1.6.13)

Industry

CPC
C12Y301/06013

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

CCHEMISTRY METALLURGY C12Biochemistry C12YENZYMES C12Y301/00Hydrolases acting on ester bonds (3.1)

Current Industry

C12Y301/06013Iduronate-2-sulfatase (3.1.6.13)

Industries

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods and compositions for CNS delivery of arylsulfatase A
- Patent number 12,168,041
- Issue date Dec 17, 2024
- Takeda Pharmaceutical Company Limited
- Nazila Salamat-Miller
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of heparan N-sulfatase
- Patent number 12,161,702
- Issue date Dec 10, 2024
- Takeda Pharmaceutical Company Limited
- Farah Natoli
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Patent number 12,121,569
- Issue date Oct 22, 2024
- Takeda Pharmaceutical Company Limited
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fusion protein comprising IDS and use thereof
- Patent number 12,098,209
- Issue date Sep 24, 2024
- MOGAM INSTITUTE FOR BIOMEDICAL RESEARCH
- Ki Joon Cho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Variant sulfatase enzymes with enhanced properties
- Patent number 12,076,377
- Issue date Sep 3, 2024
- INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.
- Lim Andrew Lee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for increasing iduronate 2-sulfatase activ...
- Patent number 12,043,661
- Issue date Jul 23, 2024
- ARMAGEN, INC.
- William M. Pardridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of mucopolysaccharidosis II with recombinant human iduron...
- Patent number 11,986,515
- Issue date May 21, 2024
- REGENXBIO Inc.
- Stephen Joseph Pakola
- G01 - MEASURING TESTING
Information Patent Grant
Adeno associated virus vectors for the treatment of hunter disease
- Patent number 11,981,912
- Issue date May 14, 2024
- Takeda Pharma ceutical Company Limited
- Vivian Choi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Aqueous pharmaceutical composition
- Patent number 11,932,699
- Issue date Mar 19, 2024
- JCR Pharmaceuticals Co., Ltd.
- Hidehito Yasukawa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for the treatment of lysosomal storage dis...
- Patent number 11,898,158
- Issue date Feb 13, 2024
- Sangamo Therapeutics, Inc.
- Edward J. Rebar
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Fusion proteins comprising enzyme replacement therapy enzymes
- Patent number 11,866,742
- Issue date Jan 9, 2024
- Denali Therapeutics Inc.
- Anastasia Henry
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for the treatment of mucopolysaccharidosis type I
- Patent number 11,857,641
- Issue date Jan 2, 2024
- Sangamo Therapeutics, Inc.
- Dale Ando
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for treating Mucopolysaccharidosis type II
- Patent number 11,819,539
- Issue date Nov 21, 2023
- The Trustees of the University of Pennsylvania
- Christian Hinderer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of mucopolysaccharidosis II with recombinant human iduron...
- Patent number 11,613,739
- Issue date Mar 28, 2023
- REGENXBIO Inc.
- Stephen Yoo
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions comprising iduronate-2-sulfatase
- Patent number 11,530,393
- Issue date Dec 20, 2022
- Takeda Pharmaceutical Company Limited
- Dave Nichols
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for producing antibody fusion protein
- Patent number 11,512,135
- Issue date Nov 29, 2022
- JCR Pharmaceuticals Co., Ltd.
- Yuri Koshimura
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CNS delivery of therapeutic agents
- Patent number 11,471,516
- Issue date Oct 18, 2022
- Shire Human Genetic Therapies, Inc.
- Pericles Calias
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Engineered target specific nucleases
- Patent number 11,401,512
- Issue date Aug 2, 2022
- Sangamo Therapeutics, Inc.
- Russell DeKelver
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatment of cognitive impairment of hunter syndrome by intrathecal...
- Patent number 11,357,832
- Issue date Jun 14, 2022
- Takeda Pharmaceutical Company Limited
- Ann Barbier
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for CNS delivery of iduronate-2-sulfatase
- Patent number 11,260,112
- Issue date Mar 1, 2022
- Shire Human Genetic Therapies, Inc.
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Gene therapy for treating mucopolysaccharidosis type II
- Patent number 11,253,612
- Issue date Feb 22, 2022
- The Trustees of the University of Pennsylvania
- Christian Hinderer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substrate clearance assays for lysosomal enzymes
- Patent number 11,187,697
- Issue date Nov 30, 2021
- Takeda Pharmaceutical Company Limited
- Vijay Chhajlani
- G01 - MEASURING TESTING
Information Patent Grant
P97-IDS fusion proteins
- Patent number 11,124,781
- Issue date Sep 21, 2021
- Bioasis Technologies, Inc.
- Timothy Z. Vitalis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Therapeutic fusion protein comprising an alpha-n-acetylglucosaminid...
- Patent number 11,065,307
- Issue date Jul 20, 2021
- Shire Human Genetic Therapies, Inc.
- Michael F. Concino
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for CNS delivery of heparan n-sulfatase
- Patent number 11,065,308
- Issue date Jul 20, 2021
- Shire Human Genetic Therapies, Inc.
- Farah Natoli
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for treating hunter syndrome
- Patent number 11,052,135
- Issue date Jul 6, 2021
- GREEN CROSS CORPORATION
- Torayuki Okuyama
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Delivering enzyme using an injectable hydrogel depot
- Patent number 11,034,950
- Issue date Jun 15, 2021
- Saint Louis University
- Adriana M. Montaño
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods and compositions for increasing iduronate 2-sulfatase activ...
- Patent number 11,028,156
- Issue date Jun 8, 2021
- ARMAGEN, INC.
- William M. Pardridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Structure, manufacturing and uses of human-derived cell-permeable p...
- Patent number 10,947,539
- Issue date Mar 16, 2021
- Portage Pharmaceuticals Ltd.
- Bruce H. Littman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fusion proteins comprising enzyme replacement therapy enzymes
- Patent number 10,870,837
- Issue date Dec 22, 2020
- Denali Therapeutics Inc.
- Anastasia Henry
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACT...
- Publication number 20240409650
- Publication date Dec 12, 2024
- ArmaGen, Inc.
- William M. Pardridge
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING IDURONATE-2-SULFATASE
- Publication number 20240401010
- Publication date Dec 5, 2024
- Takeda Pharmaceutical Company Limited
- Dave Nichols
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
AAV-IDS VECTORS FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS II
- Publication number 20240366789
- Publication date Nov 7, 2024
- The University of North Carolina at Chapel Hill
- Haiyan Fu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TARGETED DELIVERY OF THERAPEUTIC ENZYMES
- Publication number 20240350653
- Publication date Oct 24, 2024
- Joint-Stock Company "GENERIUM"
- Rakhim Rakhmankulyyevich SHUKUROV
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATE ACTIVIT...
- Publication number 20240327507
- Publication date Oct 3, 2024
- ArmaGen, Inc.
- William M. Pardridge
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITION FOR TREATING OF FACIAL DYSMORPHISM IN MUCOPOLYSACCHARID...
- Publication number 20240216481
- Publication date Jul 4, 2024
- GREEN CROSS CORPORATION
- Dong Kyu JIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SIGNAL PEPTIDES
- Publication number 20240197921
- Publication date Jun 20, 2024
- Imperial College Innovations Limited
- Jack HICKMOTT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF
- Publication number 20240148866
- Publication date May 9, 2024
- Denali Therapeutics Inc.
- Annie ARGUELLO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240117328
- Publication date Apr 11, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Nucleic Acid Molecule Containing Incorporated Gene Encoding Fused P...
- Publication number 20240066149
- Publication date Feb 29, 2024
- JCR PHARMACEUTICALS CO., LTD
- Masafumi Kinoshita
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20240058426
- Publication date Feb 22, 2024
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS COMPRISING IDURONATE-2-SULFATASE
- Publication number 20240043817
- Publication date Feb 8, 2024
- Takeda Pharmaceutical Company Limited
- Dave Nichols
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II
- Publication number 20240016903
- Publication date Jan 18, 2024
- The Trustees of the University of Pennsylvania
- Christian Hinderer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE
- Publication number 20230330195
- Publication date Oct 19, 2023
- Sangamo Therapeutics, Inc.
- Russell DeKelver
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF
- Publication number 20230310712
- Publication date Oct 5, 2023
- Takeda Pharmaceutical Company Limited
- Vincent Ling
- C07 - ORGANIC CHEMISTRY
Information Patent Application
APPLICATION OF MICROBIAL GLYCOSIDASE AS AN ANTI-VIRAL THERAPEUTIC,...
- Publication number 20230277634
- Publication date Sep 7, 2023
- The Regents of the University of California
- Cameron Martino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CNS DELIVERY OF THERAPEUTIC AGENTS
- Publication number 20230165942
- Publication date Jun 1, 2023
- Shire Human Genetic Therapies, Inc
- Pericles Calias
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
VARIANT SULFATASE ENZYMES WITH ENHANCED PROPERTIES
- Publication number 20230149519
- Publication date May 18, 2023
- INTEGRATED MICRO-CHROMATOGRAPHY SYSTEMS, INC.
- Lim Andrew LEE
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...
- Publication number 20230088992
- Publication date Mar 23, 2023
- Regenxbio Inc.
- Stephen Joseph PAKOLA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR THE TREATMENT OF HUNTER SYNDROME
- Publication number 20230092681
- Publication date Mar 23, 2023
- Denali Therapeutics Inc.
- Annie ARGUELLO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ENGINEERED TARGET SPECIFIC NUCLEASES
- Publication number 20230067653
- Publication date Mar 2, 2023
- Sangamo Therapeutics, Inc.
- Russell DeKelver
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ADENO-ASSOCIATED VIRUS PACKAGING SYSTEMS
- Publication number 20230038295
- Publication date Feb 9, 2023
- HOMOLOGY MEDICINES, INC.
- Laura VAN LIESHOUT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE
- Publication number 20230026836
- Publication date Jan 26, 2023
- Shire Human Genetic Therapies, Inc
- Gaozhong Zhu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PRODUCTION OF CATALYTICALLY ACTIVE TYPE I SULFATASE
- Publication number 20220204952
- Publication date Jun 30, 2022
- OXYRANE UK LIMITED
- Wouter Vervecken
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATIONS OF PROTEIN MOLECULES COMPRISING IDURONATE 2-SULFATASE
- Publication number 20220184186
- Publication date Jun 16, 2022
- Denali Therapeutics Inc.
- Dana ANDERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF SANFILIPPO SYNDROME TYPE B
- Publication number 20220133863
- Publication date May 5, 2022
- Shire Human Genetic Therapies, Inc
- Michael F. Concino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE
- Publication number 20220133862
- Publication date May 5, 2022
- Shire Human Genetic Therapies, Inc
- Farah Natoli
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II
- Publication number 20220125949
- Publication date Apr 28, 2022
- The Trustees of the University of Pennsylvania
- Christian Hinderer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OT...
- Publication number 20220096659
- Publication date Mar 31, 2022
- Regents of the University of Minnesota
- Kanut Laoharawee
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LYSOSOMAL STORAGE DISORDER BIOMARKERS AND METHODS OF USE THEREOF
- Publication number 20220025065
- Publication date Jan 27, 2022
- Denali Therapeutics Inc.
- Annie ARGUELLO
- C07 - ORGANIC CHEMISTRY

Iduronate-2-sulfatase (3.1.6.13)

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Methods and compositions for CNS delivery of arylsulfatase A

Methods and compositions for CNS delivery of heparan N-sulfatase

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Fusion protein comprising IDS and use thereof

Variant sulfatase enzymes with enhanced properties

Methods and compositions for increasing iduronate 2-sulfatase activ...

Treatment of mucopolysaccharidosis II with recombinant human iduron...

Adeno associated virus vectors for the treatment of hunter disease

Aqueous pharmaceutical composition

Methods and compositions for the treatment of lysosomal storage dis...

Fusion proteins comprising enzyme replacement therapy enzymes

Method for the treatment of mucopolysaccharidosis type I

Gene therapy for treating Mucopolysaccharidosis type II

Treatment of mucopolysaccharidosis II with recombinant human iduron...

Compositions comprising iduronate-2-sulfatase

Method for producing antibody fusion protein

CNS delivery of therapeutic agents

Engineered target specific nucleases

Treatment of cognitive impairment of hunter syndrome by intrathecal...

Methods and compositions for CNS delivery of iduronate-2-sulfatase

Gene therapy for treating mucopolysaccharidosis type II

Substrate clearance assays for lysosomal enzymes

P97-IDS fusion proteins

Therapeutic fusion protein comprising an alpha-n-acetylglucosaminid...

Methods and compositions for CNS delivery of heparan n-sulfatase

Methods and compositions for treating hunter syndrome

Delivering enzyme using an injectable hydrogel depot

Methods and compositions for increasing iduronate 2-sulfatase activ...

Structure, manufacturing and uses of human-derived cell-permeable p...

Fusion proteins comprising enzyme replacement therapy enzymes

Patents Applicationslast 30 patents

METHODS AND COMPOSITIONS FOR INCREASING N-ACETYLGLUCOSAMINIDASE ACT...

COMPOSITIONS COMPRISING IDURONATE-2-SULFATASE

AAV-IDS VECTORS FOR TREATMENT OF MUCOPOLYSACCHARIDOSIS II

TARGETED DELIVERY OF THERAPEUTIC ENZYMES

METHODS AND COMPOSITIONS FOR INCREASING IDURONATE 2-SULFATE ACTIVIT...

COMPOSITION FOR TREATING OF FACIAL DYSMORPHISM IN MUCOPOLYSACCHARID...

SIGNAL PEPTIDES

ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

Nucleic Acid Molecule Containing Incorporated Gene Encoding Fused P...

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

COMPOSITIONS COMPRISING IDURONATE-2-SULFATASE

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLOGIC DISEASE

IMPLANTABLE CELL CHAMBER DEVICE AND USES THEREOF

APPLICATION OF MICROBIAL GLYCOSIDASE AS AN ANTI-VIRAL THERAPEUTIC,...

CNS DELIVERY OF THERAPEUTIC AGENTS

VARIANT SULFATASE ENZYMES WITH ENHANCED PROPERTIES

TREATMENT OF MUCOPOLYSACCHARIDOSIS II WITH RECOMBINANT HUMAN IDURON...

METHODS FOR THE TREATMENT OF HUNTER SYNDROME

ENGINEERED TARGET SPECIFIC NUCLEASES

ADENO-ASSOCIATED VIRUS PACKAGING SYSTEMS

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF IDURONATE-2-SULFATASE

PRODUCTION OF CATALYTICALLY ACTIVE TYPE I SULFATASE

FORMULATIONS OF PROTEIN MOLECULES COMPRISING IDURONATE 2-SULFATASE

TREATMENT OF SANFILIPPO SYNDROME TYPE B

METHODS AND COMPOSITIONS FOR CNS DELIVERY OF HEPARAN N-SULFATASE

GENE THERAPY FOR TREATING MUCOPOLYSACCHARIDOSIS TYPE II

METHOD FOR IMPROVING NEUROLOGICAL FUNCTION IN MPSI AND MPSII AND OT...

LYSOSOMAL STORAGE DISORDER BIOMARKERS AND METHODS OF USE THEREOF